From genes to drugs: target validation in Caenorhabditis elegans
- PMID: 24981388
- DOI: 10.1016/j.ddtec.2004.09.007
From genes to drugs: target validation in Caenorhabditis elegans
Abstract
A central challenge in post-genomic drug discovery is selection of relevant therapeutic targets from a large pool of candidates, so that resources are invested productively. Key to meeting this challenge is demonstrating target function in disease-related pathways in vivo. The nematode Caenorhabditis elegans, a well-characterized experimental system for genetic analysis of biological regulatory pathways, provides a powerful means of assessing the impact of modulating target function on biological processes, thus facilitating selection of high-value targets.:
© 2004 Elsevier Ltd . All rights reserved.
LinkOut - more resources
Full Text Sources
